SUMMARY Pulmonary edema fluid was collected in 37 patients with fulminant pulmonary edema. Edema fluid (EF) and plasma (P) were assayed for colloid osmotic pressure (COP), total protein, osmolality and sodium. Electrophoresis of EF and P was determined in 16 patients. In 22 patients, multiple causes (MC group) of edema were implicated in each patient, including shock, aspiration, bacteremia, near-drowning, coagulopathy, drug overdose and pulmonary embolism. Left ventricular failure (LVF) Was also a contributing factor in some of these patients. The LVF group consisted of 15 other patients in whom LVF and/or volume overload was the primary cause of edema. The EF/P COP ratio for the MC group was 0.54-1.32 (mean ± SD 0.91 ± 0.19) and was significantly higher (p < 0.001) than that in the LVF group (range 0.28-0.69, mean ± SD 0.51 ± 0.14). In the MC group, the duration of EF production was 200 ± 433 minutes, oxygenation was poor (mean arterial/alveolar oxygen tension index 0.16 ± 0.08) and survival rate was 27%. In the LVF group, the duration was 40 ± 47 minutes, oxygenation was moderately reduced (mean ± SD 0.38 ± 0.19) and the survival rate was 66%. In most cases when the EF/P protein ratio was high, proportionately less albumin than globulin was found in EF. These data suggest that when a high content of protein is found in EF, the pulmonary microvascular membrane is damaged and edema is more severe (permeability pulmonary edema). However, the wide range of ratios and clinical findings in the MC group suggest that there is a spectrum of pulmonary membrane damage that may be complicated by LVF and/or volume overload. When edema results primarily from high pressure, the membrane remains an effective barrier to protein.
PULMONARY EDEMA is a common cause of morbidity and mortality in the critically ill. Two major types of edema have been described: hemodynamic edema, also called high-pressure edema, which is related to an increase in pulmonary microvascular pressure (Pmv), and permeability edema, which is secondary to anatomic or functional defects in the alveolar-capillary membrane. Both forms of edema have been studied extensively in experimental animals.`Key features of these studies were the measurement of the transvascular flux of fluid and protein into the lung and the ability to sample pulmonary lymph; the findings have greatly expanded our knowledge of edema. However, comparable clinical studies have not been performed. It has been suggested that analysis of pulmonary edema fluid (EF) obtained from patients may be used in lieu of sampling of pulmonary lymph to help characterize the type of edema.6 However, previous clinical reports have been based on a limited number of observations in patients.7-"
The purpose of the present study was to investigate pulmonary EF in patients with fulminant edema and to characterize the clinical features of these patients. We examined the protein content and oncotic pressure of EF vs plasma (P), together with hemodynamic and respiratory parameters and the clinical course of each patient. When possible, sequential determinations of EF were made. We found a wide range of EF/P protein and oncotic ratios, as well as a spectrum of illnesses accounting for edema. Although all patients had florid pulmonary edema, there was substantial diversity in the clinical courses. Some patients recovered rapidly; in others, the production of EF was protracted and death was a frequent end point. In general, left ventricular failure (LVF) was the predominant clinical feature in patients with an EF/P ratio < 0.6. However, in most instances the EF/P ratio was higher. In these cases, multiple factors accounting for permeability edema could be implicated in a single patient. Many of these patients had findings typical of the adult respiratory distress syndrome (ARDS).
Materials and Methods
Thirty-seven patients, ages 17-83 years, who were admitted to the Center for the Critically Ill of the Hollywood Presbyterian Medical Center from January 1975 to November 1978, were the basis for this study. This population was selected from more than.300 patients admitted to our service during that interval who had clinical or radiographic signs of pulmonary edema that included historical features of ischemic heart disease, dyspnea, tachypnea, auscultation of wet rales, ventricular (S3) gallop, arterial hypoxemia and radiographic criteria of pulmonary edema using the scheme of Turner et Abbreviations: AP = mean arterial pressure; PAP = mean pulmonary artery pressure; PA, = mean pulmonary artery wedge pressure; S = survived; D = died; COPef = edema fluid colloid osmotic pressure; COPp = plasma colloid osmotic pressure; TPef = edema fluid total protein; TPP = plasma total protein; Pao2 = arterial oxygen tension; PAO2 = alveolar oxygen tension; PaCO2 = arterial carbon dioxide tension; MC = multiple causes; LVF = left ventricular failure; IHD = ischemic heart disease; AMI = acute myocardial infarction; CPR = cardiopulmonary arrest and resuscitation; GI = gastrointestinal. Pulmonary EF was suctioned from the endotracheal tube with a soft plastic catheter and collected in a Luken's trap. Corresponding simultaneous arterial blood samples were obtained. Hematocrit was determined in duplicate on blood. In some patients, we were able to obtain multiple samples of EF and P at 10-minute intervals. If two or three hyperinflation breaths of approximately 15-18 ml/kg tidal volume were initiated just before sampling, we were able to recover larger volumes of EF. Sampling was discontinued if < 3 ml could be obtained during a sampling interval. We selected this volume to ensure that we sampled during alveolar flooding, and had an adequate sample for analytical studies. If fluid was visibly contaminated with mucus or other debris the sample was rejected. EF was yellow or pink and occasionally contained small fibrin clots. We recognized sputum contamination by the viscous quality and clarity of the EF sample.
In a separate test to assess the influence of routine lavage and suctioning on the volume and quality of fluid recovered, we instilled 10 ml of 0.9% NaCl into the airway in 10 patients with other causes of respiratory failure. In all 10 instances we were unable to recover more than 2 ml of fluid after 10 minutes. The fluid recovered in these patients was turbid and contained debris, and the protein content was < 1.0 g/dl. Therefore, lavage of the airway within 30 minutes of EF sampling or visible contamination with sputum was cause for exclusion of a sample. In the latter portion of the study, heparin (4-5 U/ml) was added to each sample to reduce clot formation.
Analysis of Edema Fluid and Plasma
Samples of EF and P were studied for protein concentration, osmolality, colloid osmotic pressure (COP) and sodium. In pink EF samples, hematocrit was also measured; in these instances the supernatant was clear. Total protein was determined by refractometry and/or the biuret reaction. COP was measured with an oncometer.13 In selected samples, protein was fractionated by means of cellulose acetate electrophoresis. In seven patients, 1 ml of radioiodinated human serum albumin (R125IHSA) containing approximately 1 1iCi/ml was injected for determination of blood volume by methods previously described.'4 R"'IHSA activity was determined in corresponding samples of EF 25 ± 5 ml/cm H20).
In 15 other patients (LVF group), acute LVF secondary to ischemic heart disease and/or volume overload was the major factor that led to edema. CPR was documented in seven of these patients. Two patients of this group showed signs of perfusion failure.
Edema Fluid
In the MC group, the mean EF/P COP ratio was high (table 2), although substantial variation was found. The duration of EF production was prolonged and oxygenation markedly reduced in these patients, and few of them survived. In contrast, the EF/P COP ratio for patients in the LVF group was low. The duration of EF production was short and oxygenation only moderately impaired, and most of these patients survived. When we excluded patients in the LVF group in whom PAW was not measured, the EF/P COP ratio and oxygenation index for the LVF group were not significantly different from those obtained when these patients were included.
The hospital survival for the 37 patients was 51%. Arterial pressure, pH, PCO, or blood lactate and the severity of edema did not seem to be related for either group. The initial mean plasma COP for the MC group was less (18.6 ± 4.8 mm Hg) than that for the LVF group (23.2 i 3.4 mm Hg) (p = NS).
PAW and the duration of EF production were related for patients in the MC group. In 10 of these patients whose initial PAW averaged 8 ± 4 mm Hg, the duration of EF production was 102 ± 90 minutes; for another 10 MC patients whose initial PAW averaged 22 t 5 mm Hg, the duration of EF production was 257 ± 200 minutes.
In six patients in the LVF group, the mean PAW was 30 ± 10 mm Hg, but in most, the PAw rapidly declined as a result of therapy. Consequently, the duration of edema was short. Aside from the COP and protein concentration, the composition of EF was remarkably similar to that of P (table 3) . There were no statistically significant differences in osmolality or sodium between EF and P.
Edema fluid was yellow and resembled P. Oc- Table 4 gives the total protein, albumin and globulin concentrations of EF and P for 16 patients. The EF/P total protein ratio was compared with the ratios for albumin and total globulin. In general, when the protein ratio was high, proportionately less albumin than globulin was found in EF. In contrast, when the protein ratio was low, a greater concentration of albumin was found in EF. This relationship, depicted as the proportion of albumin and globulin in EF and P (albumin-globulin index [A-G index] (Aef/Ap)/(Gef/GP) is shown in figure 1 . The A-G index provides an estimate of molecular sieving. The results were similar when the EF/P COP ratio was plotted (r = -0.64).
Radioiodinated Human Serum Albumin (R'26IHSA)
In seven patients, the R125IHSA activity of successive samples of EF was measured. The build-up of radioactivity in EF was appreciably greater for patients with associated with aspiration and bacteremia. Both patients died shortly after the study. In the other three patients whose ratio increased, EF production was associated with pulmonary embolism (patient 5), fresh-water drowning (patient 29) and in one patient with LVF complicated by volume overload, cardiac arrest and multiple myeloma (patient 27). The COP ratio decreased over time in patient 3, who had heroin intoxication complicated by prolonged CPR and shock; during this time, the patient was given more than 3 liters of intravenous colloidal fluids. There was no relationship in any of these seven patients between the EF/P COP ratio and the PAW.
Discussion
The most common form of pulmonary edema observed clinically is hemodynamic or high-pressure edema. This is most often caused by LVF and/or volume overload, particularly after infusion of crystalloidal fluid." Permeability pulmonary edema, however, has been linked to anatomic or functional impairment of the pulmonary microvascular membrane as a barrier to protein. In most instances, however, EF cannot be obtained from patients with either hemodynamic or permeability pulmonary edema. Only 10% of patients with pulmonary edema admitted to our service met the criteria for the present study. Accordingly, all of the patients we report suffered from severe pulmonary edema. Permeability pulmonary edema has been implicated in a variety of conditions, including aspiration of gastric contents,16 bacteremia,7 shock,'7 coagulopathy,18 drug overdose,8 pulmonary embolism,19 and near-drowning.20
Although the pathophysiology of pulmonary edema for each of these conditions has not been clarified, they have all been associated with ARDS.'7 21 In addition, the patients in the MC group had a low oxygenation index and reduced pulmonary compliance and, therefore, typify this syndrome. Our study confirms that a hallmark of ARDS is permeability pulmonary edema that is usually related to multiple causes. Under normal conditions, small quantities of fluid and protein enter the perimicrovascular space of the lung' and are removed by the pulmonary lymphatic system. Edema results when the volume of fluid entering the pulmonary perimicrovascular space exceeds the capacity of lymphatic drainage. Fluid expands the perimicrovascular space and eventually overflows into the pulmonary alveolus.
To identify the forces that may influence the move- (1) and (2) shows that a is the major factor that can be used to differentiate highpressure (hemodynamic) from permeability edema. In high-pressure edema, the membrane remains an effective barrier to protein equilibrium (a approaches 1). Therefore, the primary forces that can lead to an increase in fluid and protein flux are the hydrostatic and oncotic pressure differences and Kf. Experimental and clinical studies have shown that an increase in hydrostatic pressure leads to filtration of more fluid than protein. Accordingly, the protein content in lymph is < 50% of that of P. 23 Consequently, perimicrovascular oncotic pressure is decreased, which in turn leads to an increase in the oncotic pressure difference (irmv -prmv). This acts as a negative feedback mechanism to retard further fluid filtration. Therefore, the rate of EF production in this form is slow.
In the present study, we document a mean EF/P COP ratio of 51%o for patients in the LVF group. In the majority of these cases, left ventricular filling pressures, although high at the onset of edema, decreased rapidly as a result of therapy or the natural course of the disease. Consequently, unless cardiac competence was severely impaired, the increase in microvascular pressure that would favor continued EF production was rapidly reversed in most instances. The LVF patients usually recovered quickly, the duration of EF production was short, oxygenation only moderately reduced and the survival rate high. In addition, the low EF/P COP ratio and the slow build-up of R125IHSA in EF in these patients support the notion that in this form of edema, the microvascular membrane remains an effective barrier to protein, and the rate of extravascular fluid accumulation is moderate. Our findings are therefore analogous to experimental studies of high-pressure edema.2 23 In permeability edema, the microvascular membrane is no longer an effective barrier to protein flux (a approaches 0). In this condition, the oncotic pressure difference is reduced. Accordingly, hydrostatic pressure and Kf emerge as the major factors that influence fluid and protein movement. In experimental studies of permeability edema, small changes in hydrostatic pressure lead to substantial increases in both fluid and protein flux across the injured microvascular membrane.5 Vreim et al. reported that the protein content of EF in permeability edema usually exceeded 70% of that of P.3 In the present study, we document a high EF/P COP and protein ratio for the MC group. In these patients, the duration of EF production was protracted, oxygenation severely impaired and the survival rate low. These findings suggest that the integrity of the microvascular membrane was markedly compromised. The rapid build-up of R125I1HSA in EF also supports this view. However, we report a wide range of EF/P ratios for these patients, consistent with the notion that there is a spectrum of damage to the pulmonary microvascular membrane. The duration of EF production in this group was related to the initial PAW. When the PA, was low, the duration of fluid production was substantially less than that obtained when the PAW was high. These findings show the therapeutic importance of efforts to reduce microvascular pressure in permeability pulmonary edema. The most common cause of an elevated wedge pressure in the MC group, aside from LVF, was volume loading in an attempt to reverse perfusion failure.
Marked changes in the EF/P ratio were documented in seven patients in the MC group who had a protracted sampling interval. In most instances, the ratio increased over time. Specifically, in patient 29, with fresh-water drowning, the ratio increased from 0.54 to 1.2. Although the initial ratio is consistent with high-pressure edema, the final ratio suggests a permeability defect. In contrast, the initial ratio for patient 3 We observe a correlation between the EF/P COP or protein ratio and the A-G index. These findings are similar to previous clinical reports of EF9 1.1 on critically ill patients. This relationship suggests that there is a greater escape of globulin from the circulation in permeability than in high-pressure edema. In experimental studies of high-pressure edema, the globulin loss from the circulation was less than the albumin loss;23 in permeability edema, the proportional escape of globulin was increased.5 When the pulmonary microvascular membrane is intact, sieving of the larger protein molecules may be anticipated.
However, in a mathematical model of pore size,5 it was predicted that a tenfold increase in pore size would lead to only modest increases in the percentage of globulins in pulmonary lymph. In that simulation, increasing pore size to 1000A°did not lead to an A-G index < 1. Therefore, a low A-G index points to an increase in membrane permeability, and a high index is consistent with high-pressure edema. However, when the index is < 1 and/or the EF/P COP ratio is > 1, other possible explanations must be considered. Active transport of globulins or permeation of albumin from the alveolus and/or airway could lead to a low A-G index. 26 27 In our patients with a low A-G index, the EF/P protein ratios were high. Therefore, no Starling forces favoring permeation of albumin into the mucosa would be anticipated, and diffusion of protein would be minimal. Therefore, permeation was not a major factor accounting for the low A-G index. In patients with aspiration or other direct injury to the airway mucosa, as well as in some patients with bacteremia or severe coagulopathy, there may be active transport of globulins into EF.
In conclusion, we identify two groups of patients with fulminant pulmonary edema. Our findings support the notion that the primary difference between hemodynamic (high-pressure) and permeability edema is the degree of impairment of the pulmonary microvascular membrane. When EF can be sampled, the results may be used to classify the edema process and to estimate its severity. We present guidelines for sampling and analysis of EF. In many cases, we identified multiple factors that contributed to permeability pulmonary edema in individual patients. When this occurred, the EF/P protein ratio was likely to be high, edema production more severe and survival less likely. However, in patients with permeability edema, there is a spectrum of damage to the microvascular membrane that may change over time. The A-G index and R125IHSA build-up in EF provide additional evidence for escape of protein and the degree of membrane damage. When microvascular hydrostatic pressure is high in patients with permeability edema, the duration of edema production is protracted. Active transport of globulin may be a contributing factor in some patients, particularly when there is injury to the airway mucosa. In patients with LVF only, the edema process is less severe and the pulmonary microvascular membrane remains an effective barrier to protein.
